Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

American Society of Hematology Publications - Key Points. Forty-nine percent of relapses after CAR T-cell treatment in relapsed/refractory DLBCL occur within the first month.Risk factors for early...

BETting on stem cell expansion | Blood | American Society of Hematology

posted 20 hours

Mashup Score: 2

American Society of Hematology Publications - For decades, the expansion of hematopoietic stem cells (HSCs) has been an elusive goal. In this issue of Blood, Hua et al took a...

American Society of Hematology Publications - Key Points. With extended follow-up, ibrutinib demonstrated durable clinical benefit in patients with relapsed/refractory MZL.Biomarker data correlated with...

BETting on stem cell expansion | Blood | American Society of Hematology

posted 2 days

American Society of Hematology Publications - For decades, the expansion of hematopoietic stem cells (HSCs) has been an elusive goal. In this issue of Blood, Hua et al took a...

Volume 4 Issue 22 | Blood Advances | American Society of Hematology

posted 2 days

American Society of Hematology Publications - Read the current issue of Blood...

American Society of Hematology Publications - Abstract. Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 has transformed the natural history of relapsed and refractory B-cell acute...

Monoclonal IgM and neuropathy: not always anti-MAG | Blood | American Society of Hematology

posted 18 hours

American Society of Hematology Publications - In this issue of Blood, Le Cann et al reported a series of 45 patients with the very rare CANOMAD syndrome (chronic ataxic neuropathy,...

American Society of Hematology Publications - Key Points. Macrophage FVIIa-PAR2 signaling supports fetal liver erythropoiesis.Macrophage PAR2 signaling is dispensable for the postnatal steady-state but...